1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66DD57B9014C844AD85257C9F0055C5B5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-market-research-excellence-balancing-and-enhancing-insight-oriented-&-tracking-research-projects?opendocument
18
19opendocument
203.80.4.76
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Process Excellence and Productivity Management

Market Research Excellence: Balancing and Enhancing Insight-Oriented & Tracking Research Projects

ID: 5298


Features:

7 Info Graphics

15 Data Graphics

100+ Metrics


Pages/Slides: 30


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Market Research Excellence: Balancing and Enhancing Insight-Oriented & Tracking Research Projects"

STUDY OVERVIEW

Market research groups typically rely on both tracking research and insight research projects to inform brand and functional leaders within their organization. Different functional groups within biopharmaceutical companies utilize these research approaches to guide their strategies for increasing top-line growth as well as market position.


Best Practices, LLC conducted this benchmarking study to give leaders in the market research function insight into the practices, mix, staffing, and activity levels needed for  Market Research to consistently provide valuable, forward-looking insights into the business. Specifically, this study examines the optimal mix of insight to tracking research, the allocation of budget and staffing resources for different types of projects and the management and prioritization of ad-hoc versus planned research assignments.


KEY TOPICS

  • Balancing insight-driven research and tracking projects in the annual plan
  • Scheduling valuable planned research and building in flexibility to handle ad-hoc requests
  • Improving tracking and insight-driven research projects
  • Using lifecycle stage to guide research requirements

KEY METRICS
  • Ratio of market research staff to revenue supported, large and small company segments
  • Percent of insight-driven projects versus tracking projects
  • Brand leaders rating of various forms of tracking research
  • Examples of recent tracking projects that were well received
  • Brand leaders rating of various forms of insight research
  • Examples of recent insight-driven projects that were well received
  • Percentage of overall market research budget dedicated to tracking versus insight research
  • Percentage of overall market research staff hours dedicated to tracking versus insight research
  • Percentage of research that is planned versus ad hoc
  • Impact of tracking research based on product lifecycle
  • Product lifecycle stages when insight research provides greatest value
SAMPLE KEY FINDING
  • The allocation of most organization’s market research activities is far out of line when comparing to customer expectations and needs. Many companies are heavily skewed toward tracking projects that are not as impactful for customers as are Insight Projects. Rebalancing the mix can allow market research groups to go deeper and respond to market changes.

METHODOLOGY

Market research leaders from 14 global pharmaceutical and medical device organizations participated in this  benchmark field study and survey analysis. 

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Medical Device; Health Care; Clinical Research; Laboratories; Consumer Products; Diagnostic


Companies Profiled:
Purdue Pharma; LFB; Cochlear; Alkernes; Sanofi; actavis; Genzyme; Pfizer; Abbvie; Phillips; Amgen; Teva Pharmaceutical Industries Ltd; Bayer Healthcare

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.